This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
milla1cf Mon, 06/03/2024 - 12:36 June 3, 2024 — HighLife SAS , a medtech company focused on the development of a novel Trans-Septal Mitral Valve Replacement (“TSMVR”) system to treat patients suffering from moderate to severe Mitral Regurgitation (MR), announced today that the U.S. I am honored to lead the HighLife pivotal study.
milla1cf Wed, 05/08/2024 - 11:02 May 8, 2024 — 4C Medical Technologies, Inc. ("4C Food and Drug Administratio n ( FDA ) for the AltaValve System , a transcatheter mitral valve replacement (TMVR) device. MR occurs when blood flows backward through the mitral valve and into the atrium each time the left ventricle contracts.
Totally endoscopic robotic mitral valve repair is the least invasive surgical therapy for mitral valve disease. Robotic mitral valve surgery demonstrates faster recovery with shorter hospital stays, less morbidity, and equivalent mortality and mid-term durability compared to sternotomy.
an early-stage transcatheter mitral valve replacement (TMVR) company, following its initial investment in 2017. Combined with Edwards’ existing mitral innovations, the acquisition enhances the company’s TMVR technologies to address large unmet structural heart patient needs and support sustainable long-term growth.
(MedPage Today) -- NEW YORK CITY -- Mitral valve technology developers were urged to go back to the drawing board due to current-generation devices not meeting the needs of enough patients with mitral regurgitation (MR), some said. With lots.
Video Transcatheter-Based Mitral Valve Repair and Replacement nboden Tue, 07/17/2018 - 12:56 The latest advances in mitral valve repair and replacement include a shift toward the transseptal platform. Sloan Guy, MD, MBA – Weill Cornell/New York Presbyterian Hospital Stephen F.
We have been eagerly anticipating the opportunity to bring this innovative technology to our community. Performed through a catheter inserted into the vein, the device is guided to the heart using advanced imaging technologies. The tricuspid clip offers a lifechanging option for patients who previously had limited treatment choices.”
The sale enhances Edwards’ balance sheet flexibility for disciplined investments in technologies for aortic, mitral, tricuspid and pulmonic patients, as well as new therapeutic areas for interventional heart failure.
ADN CoE recently held an exceptional two-day training focused on the latest techniques for treating mitral valve disease. Ismail Ateş and Dr. Zeynettin Kaya; renowned experts in mitral valve interventions, this course offered an amazing opportunity for continued education. Led by Assoc. stay tuned for what's coming next.
The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transcatheter aortic valve replacement (TAVR) in 2002, as well as the first transcatheter mitral commissurotomy in 1995 and the first balloon aortic valvuloplasty in 1986. He passed away Feb. 16, 2024 at the age of 79.
ADN CoE recently hosted a groundbreaking Mitral & Tricuspid Valve Interventions Training, uniting cardiologists from around the globe for an immersive learning experience. Zeynettin KAYA, attendees gained practical insights and honed their skills in mitral and tricuspid valve interventions.
milla1cf Tue, 04/16/2024 - 12:40 April 16, 2024 — Vivasure Medical , a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced it has treated the first large bore venous patient with the PerQseal Elite vascular closure system, a sutureless and fully bioresorbable large-bore vessel closure device.
The trial was completed successfully on two patients and demonstrated mitral regurgitation sound signals are visible by the sensor when compared to normal acoustic heart signals. Today Canary Medical announced the first step in expanding our sensor technology applications outside of orthopedics.
The realm of mitral valve disease management is witnessing an unprecedented surge of advancements. Physicians understanding of disease pathology, fortified by the integration of state-of-the-art imaging technologies, has propelled them toward a new era of precision diagnosis and sophisticated treatment modalities.
Our recent Mitral Valve Training, held on January 10-11, emerged as a beacon of excellence, bringing together cardiologists from across the globe for an immersive experience. In the ever-evolving landscape of medical advancements, continuous education plays a pivotal role in shaping the expertise of healthcare professionals.
The present invention relates to medical methods for transseptal access to the heart using steerable introducers based on the Company’s Morph DNA technology. This additional patent protection for BioCardia’s current and future products in this important existing market enhances shareholder value.
Getty Images milla1cf Tue, 01/16/2024 - 14:11 January 16, 2024 — Artificial intelligence (AI) has the potential to detect rheumatic heart disease (RHD) with the same accuracy as a cardiologist, according to new research demonstrating how sophisticated deep learning technology can be applied to this disease of inequity.
Our recent Mitral Valve Training, held on January 10-11, emerged as a beacon of excellence, bringing together cardiologists from across the globe for an immersive experience. In the ever-evolving landscape of medical advancements, continuous education plays a pivotal role in shaping the expertise of healthcare professionals.
milla1cf Tue, 04/30/2024 - 13:03 April 30, 2024 — The expanding use of transcatheter technologies has changed the landscape in the treatment of valvular disease in adult cardiac patients, with valve surgery rapidly shifting to more complex interventions frequently involving other concomitant procedures.
The realm of mitral valve disease management is witnessing an unprecedented surge of advancements. Physicians understanding of disease pathology, fortified by the integration of state-of-the-art imaging technologies, has propelled them toward a new era of precision diagnosis and sophisticated treatment modalities.
Resource Multi-Valve Surgery Risk Calculator kchalko Mon, 04/22/2024 - 14:57 The expanding use of transcatheter valve technologies has changed the landscape in the treatment of valvular disease. Mitral replacement increases risk of operative mortality and other adverse outcomes compared to mitral repair.
After a medical device or intervention has been proven to be safe and effective and reasonable and necessary for coverage, CED requires innovators to monitor how their technology performs in the real world. This process leads to earlier and safer patient access to new technologies and a more direct pathway to coverage for innovators.
Shreenivas has been instrumental in advising Cardiac Dimensions on its EMPOWER Trial of the Carillon Mitral Contour System. “We I’ve seen the compelling clinical evidence on Carillon therapy from Europe and look forward to helping the team expand the supportive body of evidence for this intriguing technology with the U.S.
He added that this was the impetus to develop new transcatheter technologies that would replace open heart surgery and allow more patients living with severe tricuspid regurgitation the opportunity to receive possibly life-changing therapies. Henry Ford was one of the top 10 for patient participation nationally for these trials. “We
Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.
Additionally, the exhibit hall will provide an opportunity to discuss the latest cardiac CT technology innovations with vendors, while discussions in the poster area ofer a deep dive into current studies and applications of the latest products. AMA PRA Category 1 Credits; in addition, SCCT24 program planners note that 13.75
Although 5G technology is not available everywhere, lead-author Xianhong Shu, also of Zhongshan Hospital, said: “This system would increase the accessibility of better medical resources as patients may travel less to get diagnosis and medical advice from cardiologists based in referral centres.”
Edwards Lifesciences is going all-in on structural heart and heart failure, acquiring aortic valve-maker JenaValve Technology and implantable heart failure monitor company Endotronix for $1.2B and up to $445M in milestone payments.
In the process, improving the ejection fraction and possibly reducing mitral regurgitation. We now have one more technology, on the verge of approval by the FDA. Final message WiSE CRT uses some revolutionary technology and it is a welcome addition in few eligible patients. CRT, cardiac resynchronization therapy.
We must thank the technological innovators in the electro-anatomical mapping system, who are continuously upgrading and providing the best to us. This is what DC shocks do for temporary reversion to sinus rhythm ) How to localize the diastolic pathways ? How can we remember this EP lesson easily ?
This fellowship also will allow Dr. Fiedler and Dr. Folesani to learn novel techniques, adapt innovative technology, and receive training from expert mentors who are dedicated to the highest standards of cardiothoracic surgery. All Members Career Development Technology
The challenge, however, is that early detection is limited by currently available monitoring technologies. Three patients had simultaneous procedures: one mitral valve repair and one left atrial appendage ligation.Results:Cardiopulmonary bypass time ranged from 68 to 151 minutes, with 53 to 120 minutes of cross-clamp time.
The rapid adoption of transcatheter mitral and tricuspid therapies has also transformed the treatment landscape, expanding options for patients with structural heart disease. Transcatheter valve therapy has evolved from a novel treatment for the sickest patients to become the standard of care for many with aortic stenosis.
The rapid adoption of transcatheter mitral and tricuspid therapies has also transformed the treatment landscape, expanding options for patients with structural heart disease. Transcatheter valve therapy has evolved from a novel treatment for the sickest patients to become the standard of care for many with aortic stenosis.
Documented reports in Ghana go back to 1964 with the use of surface cooling to close atrial septal defects (ASDs) and performing a closed mitral commissurotomy at the Korle-Bu Teaching Hospital in Accra, under Charles Easmon, general surgeon and head of the Surgery Department at the hospital.
If it were me, I would get values at the level of the mitral valve, papillary muscles, and apex (all in PSS axis). Wall motion abnormalities are very hard to see, even with advanced Speckle Tracking technology. I have been wrong before though! So it is possible that I am misinterpreting the clip.
a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that surgeons have successfully performed the world’s first mitral valve replacement using the Made in India, SSi Mantra Surgical Robotic System. from 2022 to 2031.
If it were me, I would get values at the level of the mitral valve, papillary muscles, and apex (all in PSS axis). Wall motion abnormalities are very hard to see, even with advanced Speckle Tracking technology. I have been wrong before though! So it is possible that I am misinterpreting the clip.
Abbott recognized the unmet need for people with this condition and explored the use of our proven clip-based technology to find a truly life-changing intervention. Advances in Transcatheter Tricuspid Valve Technologies VIDEO: Tricuspid Device Clinical Trial Overview — Interview with Ori Ben-Yehuda, M.D.
It further reported that MHIF led the way as the first to provide this technology to a patient as part of an early research study in 2017 and completed the first-in-the-world enrollment in the pivotal trial in August 2019. TR occurs when the valve doesn't close properly, causing a leak and allowing blood to flow backward in the heart.
After half a century of evidence suggesting the existence of mineralocorticoid receptors (MR) in the vasculature, the advent of technology to specifically knockout the MR from smooth muscle cells (SMCs) in mice has elucidated contributions of SMC-MR to cardiovascular function and disease, independent of the kidney.
For more information: www.atheartmedical.com Find more technology news on congenital heart defects Find more technology news on septal defect occluders If you enjoy this content, please share it with a colleague
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)
IntroductionDespite technological advancements and new generation devices availability, transcatheter aortic valve replacement (TAVR) for bicuspid aortic valve (BAV) stenosis still presents unique technical challenges.Methods and resultsWe report an uncommon but critical complication of acute right coronary artery occlusion resulting from valve dislocation (..)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content